Endoscopic Sleeve Gastroplasty for Treatment of Obesity
1 other identifier
interventional
100
1 country
1
Brief Summary
Emerging endoscopic techniques are minimally invasive and can mimic the anatomic alterations achieved by surgical sleeve gastrectomy. The study hypothesis is if endoscopic sleeve gastroplasty is effective and useful in the treatment of patients with obesity
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Sep 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedFirst Posted
Study publicly available on registry
September 4, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedSeptember 5, 2014
September 1, 2014
1 year
September 1, 2014
September 4, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in body weight
One year
Secondary Outcomes (1)
Safety
One year
Other Outcomes (1)
Percentage of excess weight loss
One year
Study Arms (1)
Endoscopic sleeve gastroplasty
EXPERIMENTALThe intervention is an endoscopic procedure: to perform endoscopic sleeve gastroplasty we used a cap-based flexible endoscopic suturing system (OverStitch™, Apollo, Inc. Austin, Texas) mounted on a double-channel endoscope (GIF-2T160; Olympus Medical Systems Corporation, Tokyo, Japan) to achieve full-thickness, running sutures through the gastric wall from antrum to fundus.
Interventions
To perform endoluminal gastric volume reduction by the Endoscopic sleeve gastroplasty
Eligibility Criteria
You may qualify if:
- Obesity Willingness and ability of patients to be treated by a multidisciplinary team for at least 1 year -
You may not qualify if:
- Prior endoscopy discarded patients with gastric findings (potentially bleeding lesions and neoformative findings ) Coagulopathy Psychiatric disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Sanchinarro
Madrid, Madrid, 28050, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
GONTRAND LOPEZ-NAVA, MD
HOSPITAL UNIVERSITARIO SANCHINARRO
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Clinical Trial Unit
Study Record Dates
First Submitted
September 1, 2014
First Posted
September 4, 2014
Study Start
September 1, 2014
Primary Completion
September 1, 2015
Study Completion
September 1, 2016
Last Updated
September 5, 2014
Record last verified: 2014-09